We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.

AusPAR: Lisdexamfetamine dimesilate

Australian Public Assessment Report

AusPAR

AusPAR: Lisdexamfetamine dimesilate [PDF, 1.64 MB]

AusPAR: Lisdexamfetamine dimesilate [DOCX, 3.31 MB]

Attachment: Product Information: Lisdexamfetamine dimesilate [PDF, 260.68 KB]

Attachment: Product Information: Lisdexamfetamine dimesilate [DOCX, 84.24 KB]

Attachment: Extract from Clinical Evaluation Report: Lisdexamfetamine dimesilate [PDF, 1.5 MB]

Attachment: Extract from Clinical Evaluation Report: Lisdexamfetamine dimesilate [DOCX, 2.28 MB]

Device/Product Name

Vyvanse

Active ingredients

Lisdexamfetamine dimesilate

AusPAR Date

23 October 2013

Published

6 December 2013

Submission Number

PM-2012-01494-3-1

Submission Type

New chemical entity

Decision

Approved

Product types

Prescription medicines